Results 81 to 90 of about 87,711 (271)
Tumor lysis syndrome is a serious and sometimes lethal complication of cancer treatment that is comprised of a set of metabolic disturbances along with clinical manifestations.
Seema Varma, Sharonlin Bhardwaj
core +1 more source
UBE2O targets CDKL1 for the degradation to upregulate PD‐L1 expression and promotes resistance to radioimmunotherapy in lung cancer, supporting the potential of targeting UBE2O as a promising therapeutic strategy. ABSTRACT Resistance to radioimmunotherapy is one of the primary causes of treatment failure in lung cancer patients; however, the underlying
Huichan Xue +6 more
wiley +1 more source
Early Recognition and Management of Tumor Lysis Syndrome; An Oncologic Emergency
Tumor lysis syndrome is a life-threatening oncologic emergency that often occurs after initiation of cytotoxic therapies or less frequently spontaneously.
Randiak, Leah Wahito
core
This study reveals a novel GC therapy targeting cholesterol homeostasis. Inhibiting the SCAP sterol‐sensing domain causes lethal ER stress via cholesterol accumulation, paradoxically forcing continuous synthesis that triggers ferroptosis. The findings link sterol sensing, metabolic dysregulation, and ferroptosis, establishing an anti‐cancer paradigm ...
Qianqian Xu +17 more
wiley +1 more source
Porcine deltacoronavirus (PDCoV) infection induces severe intestinal inflammation and acute diarrhea in piglets, yet the molecular mechanism remains incompletely understood. The M protein activates NLRP3 inflammasome through dual mechanisms: direct binding to the NLRP3 LRR domain and disruption of TRIM31‐mediated K48‐linked ubiquitination.
Jinhui Hou +11 more
wiley +1 more source
Tumor Lysis Syndrome in Childhood
Tumor lysis syndrome (TLS) is a clinical condition that results from rapid destruction of the tumor cells and it is associated with life-threatening metabolic abnormalities. These metabolic abnormalities are hyperuricemia, hyperkalemia, hyperphosphatemia
Selçuk YÜKSEL +2 more
doaj
IRF‐1 modulates hepatic ferroptosis and aggravates liver ischemia/reperfusion injury via DYRK1α
IRF‐1 modulates hepatic ferroptosis and aggravates liver ischemia/reperfusion injury via DYRK1α. Abstract Background The purpose is to define the contribution of the interferon regulatory factor‐1–dual‐specificity tyrosine phosphorylation‐regulated kinase 1α (IRF‐1–DYRK1α) axis to hepatocellular ferroptosis during liver ischemia/reperfusion injury ...
Jinping Zhang +6 more
wiley +1 more source
Tumor Lysis Syndrome in a Retroperitoneal Sarcoma
In the present case, a 49-year-old white female presented to the clinic with a 2-month history of nausea, vomiting, and right upper quadrant pain. On examination a 3-cm mass on the right anterior scalene muscle was noted.
Yousef Zakharia MD +6 more
doaj +1 more source
Tumor lysis syndrome (TLS) is an oncological life-threatening complication characterized by hyperuricemia, hyperphosphatemia, and hyperkalemia, which can lead to acute renal failure, cardiac arrhythmias, cardiac arrest and seizures.
Tomomichi Ito +6 more
doaj +1 more source
OBJECTIVES: At present there is no published guideline that describes the corresponding nursing interventions for the prevention and management of tumor lysis syndrome.
Li, H
core +1 more source

